Share >  
Share
Share on Tumblr

Syngene International

News »

   latest by relevance
Committed to make Syngene public in FY11: Biocon
Apr 01, 2010 at 10:40 | Source: CNBC-TV18
Biocon's custom research arm Syngene International and Endo Pharma had recently tied up to discover and develop new biological drug molecules to fight cancer. Kiran Mazumdar Shaw said Biocon is committed to make Syngene public in FY11.
Biocon unit to develop drugs with US firm
Mar 22, 2010 at 16:18 | Source: Reuters
Biocon said on Monday its unit, Syngene International, has entered into an agreement with Endo Pharmaceuticals USA to develop new cancer drugs.
Biocon subsidiary enters in partnership with US co, stk up
Jan 21, 2009 at 12:14 | Source: Moneycontrol.com
Biocon had touched an intraday high of Rs 116.80 and an intraday low of Rs 103.50. At 12:04 pm, the share was quoting at Rs 114.10, up Rs 1.85, or 1.65%. The company's subsidiary Syngene International has entered into partnership with US-based Sapient for drug discovery, reports CNBC-TV18.
Syngene listing not now
Oct 17, 2008 at 08:38 | Source: The Hindu Business Line
The market meltdown has put paid to one more listing plan for now: that of Biocons custom research subsidiary, Syngene International, reports The Hindu Business Line.
Biocon's revenues Rs 1090cr, EBITDA Rs 335cr, PAT Rs 225cr
Apr 23, 2008 at 19:02
Biocon Group Revenues Rs 1,090cr, EBITDA Rs 335cr, PAT Rs 225cr. Earnings per share at Rs 22.5 for the year.
Biocon to list Syngene
Jan 18, 2008 at 08:14 | Source: The Hindu Business Line
Biocon on Thursday said it would list its subsidiary Syngene International, during the 2008-09 fiscal, reports The Hindu Business Line.

Videos »
Committed to make Syngene public in FY11: Biocon
more »

Photos »

  /  

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window